Delivery Order SPE2DB24D2101-SPE2DB25FKPAL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets in quantities of 100 units, with a contract ceiling value of $1,228.50. This delivery order represents a firm fixed-price transaction with no set-aside designation, indicating competitive award. The contract is classified as a child action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,258.58 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,538.79 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-300-40mg tablets in a quantity of 100 units. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award...
- The Defense Logistics Agency awarded a delivery order valued at $1,010.60 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100 count) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,516.31 to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine tablets (90-count) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, serves as a prime...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.63 to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine 90-count tablets, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement issued on August 4, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.85 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $25,050 firm fixed-price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under the contract, Amerisourcebergen will provide 4562018550 BUTALB-ACETAMIN-CAFF 50-325-40 100S, described as acetaminophen, butalbital, and caffeine tablets, to be delivered to a facility in Conshohocken, Pennsylvania. The single order is for a one-day period of performance from August 31, 2023 to September 1, 2023. As the DLA supports the...
- This firm fixed price delivery order, valued at $70,320, was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corporation for the supply of 100 units of 50-325mg Butalbital-Acetaminophen tablets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 29th through 30th, 2023. The Defense Logistics Agency Troop Support Medical supports the procurement and distribution needs of the Department of...
- The Defense Logistics Agency awarded a $144 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 units of Butalbital-Aspirin-Caffeine combination pills. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order runs from July 12 through July 13, 2023 to supply the DLA with this pharmaceutical product. As a top distributor of medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order from its...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPALDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This is a competitively awarded, firm fixed price contract with no set-aside designation, valued at $1,474.20 and scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's federal contracting activity demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains. This delivery order represents a component of the broader DLA pharmaceutical supply chain supporting Defense Health Agency operations and other government healthcare systems, leveraging AmerisourceBergen's established infrastructure and competitive positioning within the federal medical procurement marketplace.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/28/25 |